Search research articles
Contact Us
Filters
Showing results (11-20 of 3,059) with videos related to
Page
of 306
Sort By:
Cancer Treatment Reports
|
September 1, 1986
Chemosensitization of lomustine by misonidazole, benznidazole, and RSU 1069
P Workman
Expert Review of Anticancer Therapy
|
December 31, 2002
Cancer genome targets: RAF-ing up tumor cells to overcome oncogene addiction
Paul Workman
Current Pharmaceutical Design
|
April 8, 2003
How much gets there and what does it do?: The need for better pharmacokinetic and pharmacodynamic endpoints in contemporary drug discovery and development
Paul Workman
Molecular Cancer Therapeutics
|
February 18, 2003
Auditing the pharmacological accounts for Hsp90 molecular chaperone inhibitors: unfolding the relationship between pharmacokinetics and pharmacodynamics
Paul Workman
Seminars in Cancer Biology
|
December 1, 1992
Introduction: new anticancer drug design and discovery based on advances in molecular oncology
P Workman
Social Science Research
|
November 11, 2020
Social costs to trying hard in high school: Differences by race-ethnicity
Joseph Workman
The Chicago Medical Journal and Examiner
|
August 24, 2023
Moral Insanity-What Is It?
J Workman
QJM : Monthly Journal of the Association of Physicians
|
September 26, 2006
Cardiopulmonary resuscitation: charting a course for the future
S Workman
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|
September 25, 1999
Safe injection techniques
B Workman
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|
June 16, 2000
Peripheral intravenous therapy management
B Workman
Page
of 306
Search research articles
Search
Showing results (11-20 of 3,059) with videos related to
Sort By:
Page
of 306
Cancer Treatment Reports
|
September 1, 1986
Chemosensitization of lomustine by misonidazole, benznidazole, and RSU 1069
P Workman
Expert Review of Anticancer Therapy
|
December 31, 2002
Cancer genome targets: RAF-ing up tumor cells to overcome oncogene addiction
Paul Workman
Current Pharmaceutical Design
|
April 8, 2003
How much gets there and what does it do?: The need for better pharmacokinetic and pharmacodynamic endpoints in contemporary drug discovery and development
Paul Workman
Molecular Cancer Therapeutics
|
February 18, 2003
Auditing the pharmacological accounts for Hsp90 molecular chaperone inhibitors: unfolding the relationship between pharmacokinetics and pharmacodynamics
Paul Workman
Seminars in Cancer Biology
|
December 1, 1992
Introduction: new anticancer drug design and discovery based on advances in molecular oncology
P Workman
Social Science Research
|
November 11, 2020
Social costs to trying hard in high school: Differences by race-ethnicity
Joseph Workman
The Chicago Medical Journal and Examiner
|
August 24, 2023
Moral Insanity-What Is It?
J Workman
QJM : Monthly Journal of the Association of Physicians
|
September 26, 2006
Cardiopulmonary resuscitation: charting a course for the future
S Workman
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|
September 25, 1999
Safe injection techniques
B Workman
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|
June 16, 2000
Peripheral intravenous therapy management
B Workman
Page
of 306